Gastaldon, Chiara

Efficacy of Psychosocial Interventions for Mental Health Outcomes in Low-Income and Middle-Income Countries: An Umbrella Review

Barbui, C., Purgato, M., Abdulmalik, J., Acarturk, C., Eaton, J., Gastaldon, C., Gureje, O., Hanlon, C., Jordans, M., Lund, C., et al. (2020) · The Lancet Psychiatry

Mental Health Treatment and AccessDigital Mental Health Interventions

Cited by 349

Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises

Purgato, M., Gastaldon, C., Papola, D., van Ommeren, M., Barbui, C., & Tol, W. A. (2018) · Cochrane Database of Systematic Reviews

Mental Health Treatment and AccessPosttraumatic Stress Disorder Research

Cited by 215

Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. (2021) · Psychotherapy and Psychosomatics

Pharmacovigilance and Adverse Drug ReactionsTreatment of Major Depression

Cited by 134

Effectiveness of self-help plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial

Purgato, M., Carswell, K., Tedeschi, F., Acarturk, C., Anttila, M., Au, T., Bajbouj, M., Baumgartner, J., Biondi, M., Churchill, R., et al. (2021) · Psychotherapy and Psychosomatics

Migration, Health and TraumaMental Health Treatment and Access

Cited by 132

Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality

Schoretsanitis, G., Weiler, S., Barbui, C., Raschi, E., & Gastaldon, C. (2024) · JAMA Network Open

Pharmacovigilance and Adverse Drug ReactionsSuicide and Self-Harm Studies

Cited by 107

Esketamine for treatment resistant depression: a trick of smoke and mirrors?

Gastaldon, C., Papola, D., Ostuzzi, G., & Barbui, C. (2020) · Epidemiology and Psychiatric Sciences

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 54

Efficacy and safety of esketamine for “treatment resistant depression”: registered report for a systematic review with an individual patient data meta-analysis of randomized, double-blind, placebo-controlled trials

Naudet, F., Pellen, C., Fodor, L. A., Gastaldon, C., Barbui, C., Turner, E. H., Le Pabic, E., & Cristea, I. A. (2025) · BMC Medicine

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 6

Psychotherapeutic treatments for depression in older adults

Ang, L., Lee, M. S., Song, E., Lee, H. W., Cao, L., Zhang, J., Wang, Q., Jung, J., Jang, S., Gastaldon, C., et al. (2024) · Cochrane Database of Systematic Reviews

Psychotherapy Techniques and ApplicationsMental Health Treatment and Access

Cited by 0